_×
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > E.Coli Expressed > CDKN2D / p19ink4d Protein (GST Tag)

CDKN2D / p19ink4d Protein (GST Tag) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
12558-H09E
  YES          

Protein Production & Purification Service

Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) Protein Datasheet

 

CDKN2D / p19ink4d Protein Price Inquiry ( Available Sizes )

CDKN2D / p19ink4d Protein Product Information

Synonym : INK4D, p19, p19-INK4D 
Protein Construction: A DNA sequence encoding the human CDKN2D (P55273) (Met 10-Leu 166) was fused with the GST tag at the N-terminus. 
Source: Human 
Expression Host: E.Coli

CDKN2D / p19ink4d Protein QC Testing

Purity: >90 % as determined by SDS-PAGE.  SDS-PAGE:
SDS-PAGE

CDKN2D / p19ink4d protein

Endotoxin: Please contact us for more information.
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Met 
Molecular Mass: The recombinant human CDKN2D/GST chimera consists of 400 amino acids and has a predicted molecular mass of 44.9 kDa. It migrates as an approxiamtely 46 KDa band in SDS-PAGE under reducing conditions. 
Formulation: Lyophilized from sterile PBS, pH7.5
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

CDKN2D / p19ink4d Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

CDKN2D / p19ink4d Protein Related Products & Topics

Related Areas:

Cancer>>Cancer Biomarkers>> CDKN2D

Proteins:

Antibodies:

CDKN2D / p19ink4d Protein Description

Cyclin-dependent kinase inhibitor 2D(also known as CDKN2D or p19ink4d), a member of the INK4 family of cyclin-dependent kinase (CDK) inhibitors, negatively regulates the cyclin D-CDK4/6 complexes, which promote G1/S transition by phosphorylating the retinoblastoma tumor-suppressor gene product. It is clearly shown that DNA repair is the main target of p19ink4d effect and that diminished apoptosis is a downstream event. Experiments has uncovered a role of p19INK4d as a regulator of DNA-damage-induced apoptosis and suggest that it protects cells from undergoing apoptosis by allowing a more efficient DNA repair. It has been demonstrated that p19INK4d expression enhances cell survival under genotoxic conditions. p19INK4d expression correlates with the cellular resistance to UV treatment with increased DNA repair activity against UV-induced lesions. On the contrary, cells transfected with p19INK4d antisense cDNA show reduced ability to repair DNA damage and increased sensitivity to genotoxic insult when compared with their p19INK4d-overexpressing counterparts. Previous work has shown that inactivation of the cyclin-dependent kinase inhibitor (CKI) p19(Ink4d) leads to progressive hearing loss attributable to inappropriate DNA replication and subsequent apoptosis of hair cells. It may also involved in male reproductive function including testicular atrophy, alteration in serum follicle stimulating hormone, qualitative increase in germ cell apoptosis, and delayed kinetics of meiotic prophase markers.

References

  1. Buchold GM. et al., 2007, Mol Reprod Dev. 74 (8): 1008-20.
  2. Laine H. et al., 2007, J Neurosci. 27 (6): 1434-44.
  3. Ceruti JM. et al., 2005, Oncogene. 24 (25): 4065-80.
 

 

CDKN2D (p19ink4d) related areas, pathways, and other information